New Master’s in Transfusion Medicine and Cellular and Tissue Therapies
Leiden University Medical Center (LUMC) and Leiden University are starting a new two-year Master’s programme in Transfusion Medicine and Cellular and Tissue Therapies as of 20 October 2022. This part-time programme is entirely online and is open to students and professionals from home and abroad.
In this master’s programme professors and other experts share the latest knowledge on transfusion medicine and cellular and tissue therapies. Transfusion medicine has grown considerably in recent decades. It covers the whole path from the development to the administration of blood products, such as blood transfusions and cell therapies. Courses on the programme include: Blood Transfusion, Immunohematology, and Project Management in a Blood and Tissue Bank.
Joint master’s with Autonomous University of Barcelona
What is special about this master’s is that it is a collaboration with the Autonomous University of Barcelona (AUB). The Spanish version of this master’s has existed for longer and has been accredited since 2014. Specialists from the LUMC and AUB have been working together for ten years already within this international programme. Thanks to the intensive knowledge sharing between Leiden and Barcelona, the two institutions have created a programme that is not offered anywhere else in such a way.
Various target groups
This part-time master’s programme is entirely online, in English or Spanish, and is open to professionals and students with a bachelor’s degree in medicine, pharmacy, biological sciences and biology. Nurses with at least four years of experience in transfusion medicine can also follow the programme. Participants in the programme can take a leading role in the transfusion medicine of the future. They will gain knowledge and skills that will enable them to analyse and implement the latest developments in the field of transfusion and cellular therapies.
Pioneer in regenerative medicine
Despite many innovative developments, new challenges have also arisen. Many medical and other similar programmes take different approaches to the field, thus causing the knowledge within the field to become fragmented. The LUMC has a rich history in transfusion and transplant immunology and is seen as one of the pioneers in the field of regenerative medicine. Its researchers have been working for years on various types of cell and gene therapies.
Read more about this new joint Master’s in Transfusion Medicine and Cellular and Tissue Therapies. De opleiding is geaccrediteerd door de Nederlands-Vlaamse Accreditatieorganisatie.